Efficacy and Safety of Balloon Guide Catheter in Mechanical Thrombectomy Patients
NCT ID: NCT03754738
Last Updated: 2018-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
155 participants
INTERVENTIONAL
2018-11-25
2020-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Balloon Guide Catheter to Optimize Outcomes in Stroke Thrombectomy of the Internal Carotid Artery
NCT07192029
Balloon Guide Catheter Combined With Filter Protection for Carotid Artery Stenting
NCT07247864
Proximal TEmporary oCclusion Using Balloon Guide Catheter for Mechanical Thrombectomy
NCT05592054
BOBBY™ Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke
NCT05361187
Drug-coated Balloon Angioplasty for Patients With Symptomatic Vertebral Artery Stenosis
NCT03504657
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Balloon guide catheter group
mechanical thrombectomy with a balloon guide catheter group
Balloon guide catheter
Use a balloon guide catheter in the mechanical thrombectomy
Non-balloon guide catheter group
mechanical thrombectomy with a non-balloon guide catheter group
Non-balloon guide catheter
Use a non-balloon guide catheter in the mechanical thrombectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Balloon guide catheter
Use a balloon guide catheter in the mechanical thrombectomy
Non-balloon guide catheter
Use a non-balloon guide catheter in the mechanical thrombectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A clinical diagnosis of acute stroke, with a deficit on the NIHSS of 2 points or more.
* Intracranial arterial occlusion of the distal intracranial carotid artery or middle (M1/M2) or anterior (A1/A2) cerebral artery, demonstrated with CTA, MRA, or DSA.
* Treatment can be initiated (groin puncture) within 6 hours of symptom onset.
* Planning to mechanical thrombectomy with a stenting retriever.
* Signed informed consent prior to entering study.
Exclusion Criteria
* Previously deployed stents in the ipsilateral carotid artery.
* Dissections of the ipsilateral carotid artery.
* Known hemorrhagic diathesis, coagulation factor deficiency, or oral anticoagulant therapy with INR \> 3.0.
* Baseline platelet count \< 50.000/µL.
* Baseline blood glucose of \< 50mg/dL or \>400mg/dl.
* Severe, sustained hypertension (SBP \> 220 mm Hg or DBP \> 110 mm Hg).
* Renal insufficiency with creatinine ≥ 3 mg/dl.
* Patients in sedation and intubated patients could not be included if baseline NIHSS is not obtained by a neurologist or emergency physician prior to sedation or intubation.
* Seizures at stroke onset which would preclude obtaining a baseline NIHSS.
* Unlikely to be available for 90 days follow-up (e.g. no fixed home address, visitor from overseas).
* Subject participating in a study involving an investigational drug or device that would impact this study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ji Xunming,MD,PhD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Suzhou Municipal Hoapital
Suzhou, Anhui, China
Xuan Wu Hospital,Capital Medical University
Beijing, Beijing Municipality, China
Lu He hospital, Capital Medical University
Beijing, Beijing Municipality, China
Shengli Oilfield Central Hospital
Dongying, Shandong, China
Nanyang City Center Hospital
Nanyang, , China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, , China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zhengfei Ma, MD
Role: primary
Zongen Gao
Role: primary
Yajun Lian
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Ma H, Che R, Zhang Q, Yu W, Wu L, Zhao W, Li M, Wu D, Wu C, Ji X. The optimum anticoagulation time after endovascular thrombectomy for atrial fibrillation-related large vessel occlusion stroke: a real-world study. J Neurol. 2023 Apr;270(4):2084-2095. doi: 10.1007/s00415-022-11515-y. Epub 2023 Jan 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-ESCAPE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.